Search
Showing results for "A"
Monoclonal antibodies are revolutionizing the landscape of current cancer treatment, bringing hope to patients with incurable cancers. B7-H3 (CD276) is an attractive therapeutic target for antibody-based therapy due to its low or absent expression in normal tissues and high expression in various types of tumors, including prostate cancer, pancreatic cancer, and high-mortality esophageal squamous cell carcinoma (ESCC). In recent years, various B7-H3-targeting antibodies have been developed for cancer treatment, with a few making their way to clinical trials.
BAL Inflammatory Markers Can Predict Pulmonary Exacerbations in Children With Cystic Fibrosis Background: Pulmonary exacerbations in cystic
Quantitative assessment of airway dimensions in youngchildren with cystic fibrosis lung disease using chestcomputed tomography Abstract Objective: To
The clinical significance of oropharyngeal cultures in young children with cystic fibrosis ABSTRACT In children with cystic fibrosis (CF) the
A big congratulations to our The Kids and UWA researchers Dr Shaun Teo and Dr Paul Fournier who have both been awarded $70,000 grants for their diabetes research projects, under the 2023 Diabetes Australia Research Program (DARP).
In order to meet the rising needs of all children with type 1 diabetes and their families in WA, PCH's Diabetes Service will offer additional clinics in 2021.
After nearly two-and-a-half years in sunny Perth, Dr Tarini Chetty is headed back home to Scotland. Before she departs our shores.
Strengthening the capacity of Aboriginal children, families and communities
Improving the educational experiences of Aboriginal children and young people
The Health of Aboriginal Children and Young People